AN2 Therapeutics, Inc. (ANTX) — Insider Trading
Insider trading activity for AN2 Therapeutics, Inc. sourced from SEC EDGAR Form 4 filings.
Overview
- Total insider trades: 77
- Last trade date: Sep 16, 2026
- Ticker: ANTX
Top Insiders
- Chanda Sanjay (Chief Development Officer) — 6 trades, buy: $0, sell: $0
- FitzPatrick Margaret M — 6 trades, buy: $0, sell: $0
- Readnour Robin Shane — 4 trades, buy: $0, sell: $0
- Day Lucy (Chief Financial Officer) — 6 trades, buy: $0, sell: $0
- Marks Gilbert Lynn — 7 trades, buy: $0, sell: $0
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Trenor Cameron C. III | ANTX AN2 Therapeutics, Inc. | OTHER | 233,333 | N/A |
| Sep 15, 2026 | Trenor Cameron C. III | ANTX AN2 Therapeutics, Inc. | OTHER | 116,667 | N/A |
| Sep 9, 2026 | Readnour Robin Shane | AANTX AANTX | SELL | 1,108 | $7K |
| Sep 8, 2026 | Readnour Robin Shane | AANTX AANTX | SELL | 10,019 | $60K |
| Sep 3, 2026 | Readnour Robin Shane | AANTX AANTX | SELL | 6,100 | $37K |
| Sep 1, 2026 | Williams Sarah Joanne | AANTX AANTX | SELL | 272 | $2K |
| Aug 17, 2026 | Readnour Robin Shane | AANTX AANTX | SELL | 35,402 | $213K |
| May 29, 2026 | Williams Sarah Joanne | ANTX AN2 Therapeutics, Inc. | SELL | 265 | $1K |
| Apr 10, 2026 | Martin Patricia A. | ANTX AN2 Therapeutics, Inc. | OTHER | 1,192 | N/A |
| Apr 10, 2026 | Marks Gilbert Lynn | ANTX AN2 Therapeutics, Inc. | OTHER | 3,775 | N/A |
| Apr 10, 2026 | Aziz Kabeer | ANTX AN2 Therapeutics, Inc. | OTHER | 3,775 | N/A |
| Mar 19, 2026 | Easom Eric | ANTX AN2 Therapeutics, Inc. | OTHER | 267,650 | N/A |
| Mar 19, 2026 | Easom Eric | ANTX AN2 Therapeutics, Inc. | OTHER | 267,650 | N/A |
| Mar 19, 2026 | Easom Eric | ANTX AN2 Therapeutics, Inc. | OTHER | 225,000 | N/A |
| Mar 19, 2026 | Easom Eric | ANTX AN2 Therapeutics, Inc. | OTHER | 225,000 | N/A |
| Mar 19, 2026 | Easom Eric | ANTX AN2 Therapeutics, Inc. | OTHER | 249,999 | N/A |
| Mar 19, 2026 | Easom Eric | ANTX AN2 Therapeutics, Inc. | OTHER | 249,999 | N/A |
| Mar 19, 2026 | Readnour Robin Shane | ANTX AN2 Therapeutics, Inc. | OTHER | 23,742 | N/A |
| Mar 19, 2026 | Readnour Robin Shane | ANTX AN2 Therapeutics, Inc. | OTHER | 23,742 | N/A |
| Mar 19, 2026 | Readnour Robin Shane | ANTX AN2 Therapeutics, Inc. | OTHER | 20,724 | N/A |